1. Introduction {#sec0005}
===============

As ageing advances, a progressive decline in the ability of cells to preserve a functional proteome occurs, leading to widespread protein aggregation over time ([@bib0445]). Also, defects in cellular protein quality control mechanisms may constitute a common basis for the abnormal accumulation of proteins in age-dependent neurodegenerative disorders ([@bib0775]). In a physiological context, several levels of protein quality control exist, starting from the regulation of transcription and translation to the maintenance of proteome through clearance and repair mechanisms. Post-transcriptional control of gene expression at the level of messenger RNA (mRNA) translation and degradation is fundamental for determining protein levels, given that mRNA half-life ranges from a few minutes to many hours. Post-transcriptional mechanisms can regulate not only the amount but also the time and place of mRNAs that are translated into new proteins ([@bib0700], [@bib0715]). This regulation is vital for an organism to develop, grow and survive under both physiological and stress conditions. Furthermore, it has been shown across species that major signaling pathways that control the translation process can promote longevity and prevent age-related diseases. In this frame, cellular mechanisms and factors that direct cytoplasmic mRNAs between the translational and decay machineries or guide them to RNA granules for storage may have a great impact on the process of ageing and the development of diseases. However, current knowledge of their significance in the modulation of the ageing process and its consequences is limited. In this review, we summarize recent advances in understanding the relationship between mRNA decay and ageing and discuss the impact of key ageing modulators on mRNA turnover and vice versa. In particular, we first address the cytoplasmic mRNA decay processes that determine the half-life of normal and aberrant transcripts focusing on the latest discoveries in the field. Next, we briefly describe the major ageing pathways and mechanisms that affect lifespan in many species. Finally, we present critical findings that link mRNA decay and ageing modulators, supporting a functional interplay between them. Emphasis is given on cytoplasmic RNA granules and their factors that control mRNA turnover under normal and stress conditions, discussing their possible implications in the modulation of ageing.

2. Cytoplasmic mRNA turnover {#sec0010}
============================

Degradation of cytoplasmic RNAs is an essential cellular process, serving as a key regulator of gene expression at the post-transcriptional level, under various conditions of growth. Proper regulation of the mRNA decay process is critical for eukaryotic cells to maintain their homeostasis, not only by degrading transcripts that are no longer needed or aberrant transcripts that could lead to the production of toxic proteins, but also by stabilizing or destabilizing specific mRNAs, thus allowing a rapid fine-tuning of gene expression under changeable conditions. The fate of mRNAs in the cytoplasm is determined by a common cellular strategy: packaging of mRNAs with proteins into messenger ribonucleoprotein complexes (mRNPs) that regulate mRNA turnover.

2.1. Typical mRNA decay pathways {#sec0015}
--------------------------------

An ordinary mature mRNA consists of the spliced coding region, 3' and 5' untranslated regions (UTRs) that contain regulatory sequences important for stability and translation, as well as two extra regulatory elements that play a central role in splicing, polyadenylation, nuclear export, translation and degradation of the transcript: a cap structure at their 5' end and a stretch of adenine residues (poly(A)-tail) at their 3' end. The 5'-cap consists of methylated or trimethylated guanine and is added shortly after the initiation of transcription, while the poly(A)-tail is added during transcriptional termination of all transcripts (with the exception of histone mRNA). Both structures protect the mRNA from degradation and promote interactions that facilitate translation initiation in the cytoplasm, through 'circularization' of the mRNA molecules ([@bib0635]). The length of poly(A) tail provides a first level of translational control ([@bib0800]), with long tails having a stabilizing effect in the bulk of mRNAs, whereas poly(A)-tail shortening (deadenylation) generally initiates the degradation of mRNAs ([Fig. 1](#fig0005){ref-type="fig"}).

Deadenylation is mainly executed by the combined action of PAN2/PAN3 and CCR4/NOT deadenylation complexes ([@bib0785]) and, in most cases, is the rate limiting step of cytoplasmic mRNA decay, but is still reversible. Following deadenylation, the mRNA can be degraded in the 3'→5' direction through the action of the cytoplasmic RNA exosome, a multisubunit complex containing the DIS3 exoribonuclease. Most often though, deadenylation is followed by the removal of the 5'-cap by the decapping enzyme DCP2, exposing the 5' end mono-phosphorylated RNA to exoribonucleolytic degradation by the cytoplasmic 5'→3' exoribonuclease XRN1 ([@bib0290]). DCP1 is an essential cofactor of DCP2 in budding yeast *Saccharomyces cerevisiae*, as it interacts directly with, and introduces conformational changes in DCP2, stimulating its activity. The DCP1/DCP2 decapping complex is conserved in higher eukaryotes but additional factors are needed for their interaction ([@bib0390]). Also the DCP1/DCP2 complex communicates with a variety of enhancers or activators that act in diverse ways to stimulate decapping activity ([@bib0030]). These enhancers may serve as a scaffold for complex assembly or stimulate decapping activity indirectly by repressing translation initiation.

In addition to DCP2, a second mammalian mRNA decapping enzyme, termed NUDT16, with no obvious ortholog in *S. cerevisiae*, *Caenorhabditis elegans* or *Drosophila melanogaster*, has been found to regulate the stability of a subset of mRNAs, at least in some tissues ([@bib0705]). Further data suggest that both DCP2 and NUDT16 decapping enzymes could be differentially utilized for specific cellular mRNA decay processes ([@bib0495]). Likewise it was shown that the scavenger decapping enzyme, DCPS in mammals or DCS1 in yeast, can regulate mRNA stability in a transcript-selective manner, acting in conjunction with or as co-factor of the 5'→3' exoribonuclease XRN1 ([@bib0840]). DCPS/DCS1 is known to hydrolyze *in vitro* the residual cap structure from 3' end decay (m^7^GpppN), but its role in the degradation of the product generated by 5'→3' decay (m^7^GDP) pathway was unclear ([@bib0540]). Recent data revealed the existence of a complex process for the elimination of all free cap structures, arising as a consequence of both 5'→3' and 3'→5' mRNA decay pathway and involves DCPS/DCS1 as well as a new scavenger decapping enzyme, named APH1 in yeast or FHIT in mammals ([@bib0750]).

The two directions described above, 5'→3' and 3'→5', of cytoplasmic mRNA degradation represent the major decay mechanisms, at least in *S. cerevisiae*, and are both dependent on deadenylation. Recently, an alternative to these mRNA decay pathways has been identified in fission yeast *Schizosaccharomyces pombe* and human cells ([@bib0510], [@bib0515], [@bib0645]). It involves the uridylation of adenylated or deadenylated mRNAs, that is the addition of a short stretch of uridyl residues -often only one or two- at their 3' end by terminal uridylyl transferases (TUT4/7) and subsequent decay by multiple ways; decapping and 5'→3' degradation by XRN1 exoribonuclease, 3'→5' degradation by exosome or, degradation by a novel 3'→5' exoribonuclease, named DIS3L2, which functions independently of the exosome. Uridylation was known to be a critical step for the degradation of non-polyadenylated histone mRNAs in mammals, but the above studies suggest that addition of a uridine (U)-tract at the 3' end, of both coding and non-coding RNAs, is a broad phenomenon determining RNAs half-life ([@bib0500]).

2.2. Specialized mRNA decay pathways {#sec0020}
------------------------------------

Eukaryotic cells have also evolved specific pathways for the recognition and degradation of aberrant transcripts in a deadenylation-independent manner. Their major surveillance pathway is the nonsense mediated decay (NMD) that serves in the elimination of mRNA molecules harboring a premature translation stop codon (PTC) ([@bib0055]), albeit specific natural mRNAs can be also regulated by NMD in many organisms ([@bib0620]). The recognition of a PTC during translation leads to translational repression, ribosome release/recycling and accelerated mRNA decay by either endonucleolytic cleavage or recruitment of decapping enzymes, the 5'→3' exoribonuclease XRN1 and various exosome components, promoting degradation of the targeted mRNA in both directions ([@bib0435]). A second surveillance mechanism, the no-go decay (NGD), is activated when translational elongation is stalled due to a wide range of events, including strong secondary structures or contiguous rare codons. NGD leads to endonucleolytic cleavage and subsequent degradation of the 5' and 3' products ([@bib0185]). Finally, the non-stop decay pathway (NSD) is triggered when ribosomes fail to encounter an in-frame stop codon during translation, reaching the poly(A)-tail of the transcript. Stalled ribosomes at the 3' end of mRNAs lead to the recruitment of the SKI complex, causing rapid degradation by the exosome, while a contribution of the 5'→3' degradation machinery is possible ([@bib0855]). An additional specific mRNA decay mechanism is the regulated IRE1-dependent decay (RIDD) that targets mRNAs localized to the ER membrane to maintain ER homeostasis under stress ([@bib0330]) or in certain physiological conditions ([@bib0135]).

Therefore, mRNA decay can be triggered in a transcript-specific manner through the interaction of mRNAs with specific RNA-binding proteins (RBPs). Examples include the UPF proteins that are the key regulators of the NMD pathway or the PUF proteins that recognize specific *cis*-acting elements in 3' UTR of mRNAs and promote translation repression and/or deadenylation, decapping and degradation across species ([@bib0545]). In mammalian cells, a common *cis* element that confers instability to an mRNA is the AU-rich element (ARE), identified in the 3' UTR of 5--8% of human mRNAs, encoding for proteins of diverse functions ([@bib0040]). Several ARE-binding proteins (ABPs) have been identified, including the HuR, AUF1, BRF, TIA-1 and TTP, which regulate mRNA stability and translation through their interaction with AREs. Some of the ABPs stimulate rapid degradation of mRNAs, via both directions, while others can stabilize their target mRNAs preventing their decay, e.g. when confronted with stress ([@bib0860]). They have important physiological and pathological functions, as they are implicated in tightly regulated processes, like immune response and inflammation, cell cycle and carcinogenesis. Similar to AREs, but far less studied, is the family of GU-rich elements (GREs), found in the 3' UTR of many human mRNAs that are involved in processes like cell growth, migration and apoptosis, conferring transcript instability ([@bib0780]). Another type of *trans*-acting factors that recognize specific *cis* elements on the target mRNA, the non-coding miRNAs, regulates the steady-state transcript levels of a large number of genes in animals and plants by promoting silencing and/or degradation (discussed below). Of note, miRNAs can interact with ABPs, which are able to promote or antagonize their function and in turn, miRNAs may modulate the expression of ABPs themselves ([@bib0235], [@bib0615]).

2.3. RNA granules regulating mRNA turnover {#sec0025}
------------------------------------------

In eukaryotic cells, components of the 5'→3' decay have been found to colocalize and exert their function in distinct cytoplasmic foci termed processing bodies (PBs) or P-bodies ([Fig. 1](#fig0005){ref-type="fig"}), initially referred to as GW bodies in mammalian cells ([@bib0230], [@bib0690]). PBs have been characterized as cytoplasmic sites of mRNA decay and storage of translationally repressed mRNAs, as they harbor non-translating mRNAs and several proteins implicated in the translational silencing and degradation of transcripts ([@bib0160], [@bib0760]). Both CCR4-NOT and PAN2-PAN3 deadenylation complexes, the decapping complex and the 5'→3' exoribonuclease XRN1 are localized to PBs, but not exosome subunits or the scavenger decapping enzyme DCS1 ([@bib0085], [@bib0160], [@bib0755]). The newly identified 3'→5' exoribonuclease DIS3L2, in fission yeast, localizes in cytoplasmic foci which are docked to PBs ([@bib0515]). Moreover, PBs have been found to contain degradation intermediates, components of aberrant mRNA surveillance pathways, as well as proteins involved in ARE- or miRNA-mediated degradation of transcripts, suggesting that they are active sites of mRNA decay and not just storage places of the decay machinery ([@bib0460]). In *S. cerevisiae*, PBs also function in the elimination of mature but aberrant 18S rRNAs, which are subjected to a cytoplasmic quality control mechanism named nonfunctional RNA decay (NRD), the latter being mechanistically related to no-go mRNA decay ([@bib0145]).

Nonetheless, mRNA degradation in yeast, *Drosophila* and human cells seems to begin while transcripts are still associated with ribosome complexes ([@bib0015], [@bib0220], [@bib0345], [@bib0340], [@bib0625]). Also, under conditions that impair PB formation, all related functions continue to occur in the cytoplasm ([@bib0220], [@bib0725]) making obscure the reasons for their assembly; it might be crucial for fine-tuning regulation of mRNAs' fate, e.g. to strengthen mRNA decay rate and/or specificity, along with keeping silenced mRNAs away from translational machinery. PBs are highly dynamic foci, constantly present in the cytoplasm under normal conditions, but rapidly increased in number and size upon exposure to various forms of stress ([@bib0420], [@bib0650], [@bib0760]) ([Fig. 2](#fig0010){ref-type="fig"}). The rate limiting step in their assembly is the presence of translationally incompetent mRNAs, since a decrease in their abundance by trapping mRNAs into polysomes or inhibiting transcription results to reduced PBs, while an increase in the pool of non-translating mRNAs by blocking their degradation or translation initiation increased PBs in yeast, worms and mammals ([@bib0160], [@bib0690], [@bib0760]). The release of an mRNA from the translation machinery seems to be a perquisite for its targeting to PBs, since ribosomal proteins and translation initiation factors are excluded from PBs with the exception of eIF4E. The simultaneous presence of eIF4E-T (an eIF4E-binding protein that inhibits translation) however suggests that eIF4E is associated with translationally repressed, not active, molecules ([@bib0010], [@bib0240]). Conversely, not all mRNAs found in PBs are committed to decapping and decay and intact transcripts can exit PBs and return to translation ([@bib0060], [@bib0085]).

PBs have frequently been found to physically and functionally interact with a second type of cytoplasmic RNA granules, named stress granules (SGs). These are also dynamic structures containing non-translating mRNAs but they differ from PBs in the aspect that they harbor poly(A)^+^ mRNAs, translation initiation factors, PABP and 40S ribosomal subunits, but lack enzymes of the mRNA deadenylation and degradation machinery ([@bib0420], [@bib0440]). Their composition suggests that SGs are aggregates of mRNPs stalled in translation initiation step, probably formed to protect sequestered mRNAs from degradation until the cell recovers. Indeed, SGs become microscopically visible only under environmental stress, where translation initiation is generally inhibited or as a result of genetic manipulations and addition of drugs that impair translation initiation ([@bib0090]). Also, stress-induced SGs stabilize and accumulate labile mRNAs, such as ARE- or NMD-targets, through the recruitment of cognate RNA-binding proteins ([@bib0860]). However, translational arrest does not always induce the formation of SGs, indicating that proteins and non-translating mRNAs move to SGs under specific conditions ([@bib0570], [@bib0595]). Despite their differences though, PBs and SGs share many common proteins and mRNA species whilst under certain stress conditions, a dynamic relationship between them has been observed; they can interact, dock for a short period of time, presumably in order to exchange components, fuse or mature from one type to another ([@bib0095], [@bib0175], [@bib0420], [@bib0810]). The dynamic nature of PBs and SGs probably reflects their capacity to respond quickly and transiently to various cellular signals. Global analysis of yeast mRNPs during stress revealed that a widespread relocalization of mRNA-binding proteins occurs concluding that subcellular rearrangement of PBs and SGs is a major and global response to stress ([@bib0565]).

Apart from SGs, PBs can interact with other RNA granules found in specific cellular subsets, like neuronal transport granules and germ granules in embryonic cells, involved in spatiotemporal control of translation of neuron-tethered and maternal mRNAs, respectively ([@bib0275], [@bib0830]). It is notable that PBs as well as their related SGs and germ granules have been found to associate with membrane-bound organelles such as mitochondria and endosomes, linking mRNA silencing and decay with these organelle functions ([@bib0795]). Two other types of RNA granules that have been reported to regulate mRNA stability and decay are the yeast UV granules, containing UV-damaged mRNAs and the mammalian exosome granules harboring ARE-mRNAs ([@bib0265], [@bib0505]). The dynamic and reversible segregation of cytoplasmic components into these RNA granules and the interactions observed between them outline a complex model for the life-cycle of cytoplasmic mRNAs; specific transcripts can quickly change their binding partners, forming different mRNPs, while granule components can shuttle between RNA granules and active polysomes. All together these interactions ultimately determine the fate of mRNAs concerning translation, localization, storage and decay.

3. Ageing mechanisms and pathways {#sec0030}
=================================

Ageing is generally considered as long-term accumulation of cellular damage, evoked by intrinsic or extrinsic assaults, which interferes with the normal functioning of cellular networks and disturbs organismal homeostasis. Over the past few years, genetic studies of longevity in classic model organisms have identified many genes, mechanisms and pathways that cause or slow ageing, and are often highly conserved through evolution. They can modulate lifespan mostly by enhancing cellular stress resistance, maintaining cellular homeostasis and altering metabolism of the organism. In addition, most of them are of vital importance to counteract age-associated disability and diseases like Parkinson's, Alzheimer's and Huntington's disease.

3.1. Signal transduction pathways {#sec0035}
---------------------------------

Multiple signaling pathways that integrate hormonal, nutrient and stress signals have emerged as important modulators of ageing or age-related phenotypes. The first pathway shown to almost double the lifespan of *C. elegans* was the insulin/insulin-like growth factor-1 (IGF-1) signaling (IIS) pathway ([@bib0430]). It is evolutionary conserved and its down-regulation promotes longevity in organisms as diverse as worms, flies and mice; moreover genetic variations in IIS components have been associated with longevity and healthy ageing in humans ([@bib0050], [@bib0555]). The IIS in worms is initiated when insulin-like peptides bind to the single receptor DAF-2 and activate a downstream kinase cascade, leading to the phosphorylation of DAF-16, a homolog of the mammalian FOXO family of transcription factors. Phosphorylated DAF-16 is retained in the cytoplasm while reduced IIS, due to genetic mutations or hormonal/stress signals, negatively regulates the phosphorylation of DAF-16 and allows its translocation to the nucleus. Changes in expression of the DAF-16 gene targets, involved in stress resistance, immune defense and metabolism, can ultimately prolong lifespan. Nuclear translocation of DAF-16 can be induced by key mediators of stress and immune signal transduction pathways, such as c-JUN N-terminal kinase (JNK) and p38 kinases, linking these pathways to longevity and stress resistance in *C. elegans* ([@bib0450], [@bib0590]).

An evolutionary conserved pathway that interacts with IIS and integrates stress, nutrient, energy and hormone signals is the mTOR (mechanistic target of rapamycin) signaling pathway ([@bib0820], [@bib0845]). Like IIS, genetic mutations or drugs that reduce mTOR signaling can extend lifespan in model organisms and protect against neurodegeneration ([@bib0155], [@bib0380]). The effects of mTOR in longevity are closely connected to its downstream regulated processes, such as protein translation, ribosome biosynthesis, lipid synthesis, autophagy, stress response etc. ([@bib0255]). Direct genetic manipulations of mTOR pathway components or downstream targets can alter lifespan in many different organisms, whereas treatment with rapamycin, an inhibitor of mTOR, has been shown to increase lifespan in yeast, worms, flies and, even in mice when initiated late in life ([@bib0065], [@bib0070], [@bib0410], [@bib0765]). Interestingly, at the metabolic and molecular level, mTOR inactivation mimics the effects of dietary restriction (DR), a reduction in nutrient intake without malnutrition ([@bib0410]). DR prolongs lifespan and opposes the late-onset disability and diseases, in diverse species, whereas studies in primates indicate that DR provides an overall health benefit ([@bib0560]). The underlying mechanisms seem to be relevant to common strategies of cells and organisms that have evolved to cope with nutrient scarcity and stress. Consistent with this, the activation of SIR2 pathway in response to DR or starvation has been linked to longevity. SIR2 in yeast and its functional orthologs in other organisms, that make up the sirtuins family, are NAD^+^-dependent protein deacetylases that act as sensor of the metabolic state of the cell and organism; thus, they have important functions in multiple physiological processes, affecting several human diseases and ageing-associated metabolic and cognitive disorders ([@bib0365]).

3.2. Protein synthesis and homeostasis {#sec0040}
--------------------------------------

Organisms are constantly exposed to a range of stressful stimuli that perturb their homeostasis and, an important part of the coordinated cellular response that takes place is the control of protein synthesis. Upon nutrient limitation or environmental stress conditions, mTOR signaling, a master regulator of protein synthesis is inhibited whereas, the eIF2α (eukaryotic initiation factor 2α) kinase GCN2 (general amino acid control non-derepressible) is activated; although they utilize distinct mechanisms, both are able to initiate a general shutdown of protein synthesis accompanied by specific mRNAs' translation. This translational control elicits an adaptive response that allows cells to survive by saving energy and by selective induction of stress-resistance proteins ([@bib0715]). Evidence from several model organisms has established that regulation of global protein synthesis is a common determinant of longevity, as altering the expression of translation factors to reduce mRNA translation can increase lifespan and stress resistance in animal models ([@bib0025], [@bib0740]). The same mechanisms of translational regulation may contribute to lifespan extension and metabolic fitness conferred by DR ([@bib0270]). Quantitative proteomic studies further support this idea as the proteome profile of both dietary restricted and IIS mutant worms is characterized by the decreased abundance of proteins involved in mRNA translation and protein metabolism ([@bib0180], [@bib0190], [@bib0730]).

A global reduction in mRNA translation could also preserve protein homeostasis (or proteostasis) by preventing the production of excessive amounts of proteins, some of which might be undesirable for normal cellular function. It has been shown that not only the intrinsic tendencies of proteins to aggregate but also their high cellular levels can drive their aggregation into non-functional and sometimes cytotoxic structures ([@bib0130], [@bib0200], [@bib0790]). Although cells have evolved an elaborate network of proteolytic systems to safeguard proteome integrity and ensure proteostasis, the functionality of these systems is challenged by stress, ageing or pathologies, resulting in the widespread aggregation of proteome that occurs under these conditions ([@bib0170], [@bib0600], [@bib0640], [@bib0790]). In aged cells, increased oxidative damage of proteins can also lead to aggregates such as lipofuscin and advanced glycation end-products (AGEs) ([@bib0720]). A decline in proteostatic control with age further aggravates the ageing phenotypes and a causal link between ageing and proteotoxicity has been established by several studies, as genes and signaling pathways that extend lifespan can also restore proteostasis ([@bib0140], [@bib0170], [@bib0335], [@bib0580]). The cellular protein quality control networks include molecular chaperones, in the cytosol or organelles, which facilitate the proper folding of proteins but can also recognize misfolded proteins and assist in their refolding, at a first level of proteome protection ([@bib0105], [@bib0320]).

On the next level, the irreversibly damaged proteins can be targeted for degradation by the ubiquitin-proteasome system (UPS) or the autophagosome-lysosome pathway. The UPS-mediated proteolysis of proteins relies on their conjugation to several ubiquitin units and subsequently their recognition, translocation and degradation by the proteasome, in an ATP-dependent manner ([@bib0250]). The second proteolytic pathway, the lysosomal guided by autophagy, can degrade damaged cytoplasmic proteins and organelles, providing both cytoprotection and recycling of macromolecular constituents, especially under energy-limiting or stress conditions ([@bib0325]). These proteolytic pathways are also involved in normal aspects of cell development and physiology and must be properly regulated to maintain cellular homeostasis; defects in both processes are associated with a range of diseases in humans, while their activities are affected by ageing in several mammalian tissues and cells ([@bib0775]). Strikingly, studies on several experimental systems have established a link between increased proteasome activity and longevity or protection against age-related diseases ([@bib0125]). Likewise, activation of autophagy by genetic or pharmacological means promotes longevity and protects against neurodegeneration ([@bib0315]). In agreement with this, DR is a potent inducer of autophagy in all species, and many of the anti-ageing effects of DR are attributed to autophagy induction ([@bib0310]). Similarly, other known ageing modulators, such as ISS and sirtuin/SIRT1, can stimulate autophagy ([@bib0475], [@bib0525]) expanding the cytoprotective role of autophagy in lifespan extension.

3.3. miRNA functions {#sec0045}
--------------------

MicroRNAs (miRNAs) are a class of small, non-coding RNAs (∼22 nucleotides long), which typically down-regulate gene expression at the post-transcriptional level, by base pairing to mRNAs and targeting them for degradation or translational repression. They are conserved, key regulators of many biological processes, as more than half of all mRNAs are estimated to be targets of miRNAs and each miRNA is predicted to regulate the expression of hundreds of target genes ([@bib0045]). Due to this functional redundancy, less than 30% of the ∼150 identified miRNAs in *C. elegans* have known specific functions and this shortcoming is exaggerated in humans where more than a thousand miRNAs exist (stand for ∼3% of the total number of genes). However, it is now well-appreciated that miRNAs regulate a broad range of gene expression, even if their impact may be seen only in specific developmental stages, tissues, sensitized genetic background or stress; ultimately they help to confer robustness in nearly all biological processes, including development, growth, metabolism, tissue homeostasis, stress responses and ageing ([@bib0195], [@bib0485]). As expected, alterations in miRNA expression have been linked to several human diseases, such as cancer, metabolic disease and viral pathogenesis, making miRNAs promising candidates for diagnostic markers and therapeutic targets ([@bib0305], [@bib0530]). Interestingly, recent data associate many miRNA families with various nutrient interventions that act through the above mentioned nutrient sensing pathways to modulate healthy lifespan in most organisms ([@bib0280], [@bib0605]).

The first two miRNAs, *lin-4* and *let-7*, were discovered in *C. elegans*, where they function in the temporal control of cell fates, regulating developmental timing events, but can also modulate adult lifespan ([@bib0075], [@bib0685]). Analysis of the miRNA expression during ageing using microarrays ([@bib0360]) or deep-sequencing ([@bib0850], [@bib0415]), revealed that a significant number of miRNAs change (most are down-regulated) during ageing, and their predicted targets are involved in cellular homeostasis and stress response signaling. Likewise, differential expression during ageing has been demonstrated for many miRNAs in mice, humans and primates, in a tissue-specific pattern ([@bib0370], [@bib0535]). A decline of DICER RNase and miRNA processing with age has been observed in both worms and mice, while loss of DICER or other miRNA-associated factors reduces lifespan and stress tolerance, indicating a crucial role of miRNA function in ageing and stress response ([@bib0415], [@bib0480], [@bib0575]). Studies in invertebrates and mammals revealed that miRNAs can modulate lifespan and age-associated processes, positively or negatively, by targeting components of known longevity modulators such as IIS, mTOR, DR, steroid signals and mitochondrial function, linking miRNA function and ageing in humans ([@bib0285], [@bib0400], [@bib0695]).

4. The connection between ageing modulators and cytoplasmic mRNA turnover {#sec0050}
=========================================================================

In recent years, we have put plenty of emphasis on the effects of various signaling pathways on the regulation of transcription of specific mRNAs that can modulate ageing and age-related disorders. However, gene expression is equally determined by the rate of mRNA translation and degradation. Post-transcriptional control is also an integral part of cellular stress response, where RNA granules that regulate mRNA turnover seem to have important functions. Mechanisms and signaling pathways that further control protein levels have gained much attention as lifespan determinants in view of maintaining protein homeostasis during ageing. The impact of mRNA decay factors and related RNA particles in controlling mRNA and protein levels during ageing and stress though remains largely unexplored, while the influence of ageing modulators on mRNA decay factors or their interacting proteins has been underappreciated.

4.1. Signal transduction pathways and mRNA turnover {#sec0055}
---------------------------------------------------

A growing body of evidence suggests that different signal transduction pathways with pivotal role in lifespan and stress response of diverse organisms can influence the levels or activity of mRNA decay factors in response to cellular or external stimuli. In both *C. elegans* and humans, the scavenger mRNA decapping enzyme DCS1, is coordinately expressed with a cytosolic NADPH-dependent flavin reductase, known as FRE-1 in worms and NR1 in humans. Induction of *dcs-1* and *fre-1* genes by heat-shock suggests a role of both proteins in stress response of worms ([@bib0465]), whereas menadione-induced cytotoxicity in human cells that overexpress NR1 can be significantly reduced by DCS1, which physically interacts and inhibits NR1 activity, promoting cell survival ([@bib0470]). Likewise, nutrient stress in *S. cerevisiae* induces transcription of the DCS1 gene via the cAMP-PKA signaling pathway, with DCS1 to inhibit the activity of neutral trehalase, NTH1, an enzyme regulating trehalose hydrolysis ([@bib0520], [@bib0670]). The disaccharide trehalose is accumulated during various stress conditions and stabilizes cellular components in many invertebrates. Remarkably, trehalose levels are elevated in several long-lived worms, such as *daf-2* mutants of the IIS pathway or *ife-2*/eIF4E translation factor mutants and are considered as one of the metabolic signatures of long-life in *C. elegans* ([@bib0260]).

Major signal transduction pathways can affect the localization and function of mRNA turnover factors, constituents of cytoplasmic RNA granules. In yeast, phosphorylation of DCP2 decapping enzyme in response to oxidative stress or glucose deprivation was shown to affect its localization to PBs, to promote SG formation and to stabilize a subset of mRNAs encoding ribosomal proteins ([@bib0825]). Similarly in mammalian cells, phosphorylation of DCP1a by JNK in response to stress or inflammatory stimuli regulates localization of DCP1a to PBs affecting the mRNA levels of NF-kB target genes ([@bib0660]). Human DCP1a is also phosphorylated via the ERK pathway during early differentiation of preadipocytes, enhancing its association with DCP2 ([@bib0120]). In addition, several types of stresses that induce eIF2α phosphorylation and translational repression promote SG formation and alter gene expression.

A number of signaling pathways can also target various RNA-binding proteins (RBPs) that regulate mRNA stability and translation by promoting conventional or specific decay pathways such as NMD or ARE-mediated mRNA decay ([@bib0090], [@bib0680], [@bib0770]). Several SG-associated RBPs undergo post-translational modifications such as phopshorylation, ubiquitination, *N*-acetyl glucosamination, methyl-argininylation and poly ADP-ribosylation, which in turn promote assembly of stalled mRNPs into SGs. Their assembly could alter signaling activity by interrupting and sequestering signaling components or by regulating cellular responses to various stimuli ([@bib0425]). For example, sequestration of RACK1 scaffold protein at SGs in mammalian cells inhibits apoptotic death by suppressing the stress-induced activation of p38 and JNK signaling pathways ([@bib0020]). Interestingly enough, SGs assembly in both yeast and human cells alters mTOR signaling during nutrient- or heat-stress by recruiting and inactivating TOR complex 1 (TORC1) and downstream kinases ([@bib0745], [@bib0815]). During recovery from stress, TORC1 reactivation correlates with SG disassembly ([@bib0745]). The vast majority of mTOR targets are mRNAs that contain 5'-terminal oligopyrimidine tracts and one mechanism of translation repression of such mRNAs during amino acid starvation involves the binding of such tracts by the SG-associated TIA-1 and TIAR proteins ([@bib0165]).

In turn, alterations in the activity of cytoplasmic RNA granules' components could affect the function and outcomes of known ageing-associated signaling pathways. Defects in mRNA silencing/decay factors in PBs might influence the levels of proteins and miRNAs that are either targets or regulators of those signaling pathways. In *C. elegans*, loss-of-function mutations in genes encoding mRNA decay factors, such as the decapping complex or decapping activators, have negative effect on lifespan and stress resistance of wild-type animals but also reduce the long life, thermotolerance and pathogen resistance of *daf-2* mutants with diminished IIS pathway ([@bib0150], [@bib0650]). Moreover, loss of decapping activity shortens lifespan of dietary restricted, translation defective or germline-deficient worms ([@bib0650]). In addition, disruption of other PB components, such as the 5'→3' exonuclease XRN-1, the translation repressor GCH-1/DHH1/RCK or the core miRNA complex components ALG-1 or AIN-1/GW182 leads to reduced worm's lifespan ([@bib0415], [@bib0650], [@bib0665]). It was also shown that deficiency of SIR-2.4, the worm homolog of mammalian SIRT6 and SIRT7 sirtuins, renders worms hypersensitive to heat and oxidative stress; SIR-2.4 promotes formation of P granules in germ cells of *C. elegans* or SGs in mammalian cells ([@bib0375]) and modulates localization and function of DAF-16/FOXO transcription factor under stress ([@bib0115]).

4.2. Protein synthesis/homeostasis and mRNA turnover {#sec0060}
----------------------------------------------------

mRNA translation is a process closely coupled to, and often in competition with mRNA decay, but this interaction is affected by the status of the individual mRNA (translatable, repressed or aberrant) and its translocation into PBs or SGs ([@bib0005], [@bib0085]). In response to environmental or cellular signals that inhibit translation, not-translating mRNAs accumulate in these granules for degradation or storage and recovery. Both granules are increased during stress in yeast, mammalian and *Drosophila* S2 cell cultures, but also in stressed or arrested oocytes of worms and flies ([@bib0395], [@bib0585], [@bib0675]). In consistence, both PBs and SGs are formed in somatic cells of *C. elegans* in response to stress and the increased stress sensitivity of worm mutants for components of these granules reflect their crucial role under these conditions ([@bib0150], [@bib0650], [@bib0735]).

Furthermore, the reduced lifespan of decapping mutants suggests a link of mRNA decay with ageing. Fluorescent protein markers of PBs have been monitored to accumulate in an age-dependent manner in somatic cells of adult worms ([@bib0650]) ([Fig. 2](#fig0010){ref-type="fig"}). This accumulation can be attributed to a mild oxidative stress in aged tissues or to an overall reduction of mRNA translation/degradation or protein quality control mechanisms that accompany ageing. At least in *C. elegans*, ageing is associated with a progressive loss of proteome balance due to a decrease in ribosomal subunit proteins, along with a relief of miRNA-mediated translational repression ([@bib0790]). Both cause proteostasis stress and drive a widespread aggregation of the resulting aberrant proteins as part of a protective cellular response to maintain proteostasis, given that all *C. elegans* somatic cells are post-mitotic and have no self-renewal capacities ([@bib0790]). It is tempting to speculate that aggregation of PBs with age might contribute to proteostasis control by enhancing the efficiency of mRNA degradation, silencing or miRNA-mediated repression that take place into them. Maintaining of protein homeostasis is a key factor in the modulation of the ageing process but also in age-related neurodegenerative diseases, where specific peptides/proteins misfold and aggregate ([@bib0300], [@bib0445]). Interestingly, current studies in yeast and mammalian cells have revealed a spatial sequestration of misfolded proteins into distinct protein quality control compartments (Q-bodies, JUNQ and IPOD) to undergo refolding or clearance of toxic species ([@bib0710]). Thus, aggregation of cellular components in general might be protective, at least at the first stages of cellular dysfunction that is caused during ageing, stress or neurodegerative diseases ([@bib0550]).

The removal of potentially toxic protein aggregates is achieved by the ubiquitin-proteasome system (UPS) or the autophagosome-lysosome pathway. Latest data have unveiled an intimate relationship between these proteolytic mechanisms and cytoplasmic mRNA degradation. A recent study revealed that the ubiquitin proteasome system can regulate the levels of the mRNA degradation enzyme DCP2, to ensure proper control of its cellular activity. A C-terminal domain of the human DCP2 was found to be responsible not only for the interaction with a scaffold protein that stimulates the assembly of the decapping complex, but also for the degradation of unbound DCP2 by the proteasome; this might serve to maintain the appropriate levels of DCP2 protein relative to the remaining components of the decapping complex, or regulate its levels according to cellular cues ([@bib0210]). In addition several mutations that disrupt autophagy were found to stabilize SGs and PBs in the cytoplasm of budding yeast, while blockades in the late steps of autophagic vesicle breakdown lead to the accumulation of PBs and SGs markers in an intravacuolar compartment. This targeting of RNA granules to the vacuole by autophagy was referred as "granulophagy" and may provide a mechanism for efficient PBs/SGs clearance, regulating their abundance during stress and development, serving in parallel as a means for the mass degradation of mRNA molecules that reside inside them ([@bib0100]). A similar mechanism has been found to occur during *C. elegans* embryonic development, where germ-line specific mRNPs (P-granules) are selectively removed from somatic cells through autophagy ([@bib0835]).

Conversely, the function of the mRNA decay machinery seems to affect the process of autophagy under stress conditions. Inactivation of TOR kinase pathway upon nutrient limitation in yeast was shown to prevent phosphorylation of the decapping enzyme DCP2, causing dissociation of the DHH1/RCK decapping activator from autophagy-related (*atg*) mRNAs. Thus, *atg* transcripts are not degraded by the 5'→3\' mRNA decay pathway and induce autophagy and cell survival ([@bib0350]). What is more, stress induced inhibition of the NMD pathway, responsible for the degradation of aberrant mRNAs, can stimulate autophagy in several mammalian cell lines, due to the accumulation of the resulting aberrant protein products and/or the stabilization of NMD target mRNAs involved in the induction of autophagy ([@bib0805]). These observations suggest a role for NMD inhibition in the augmentation of cellular stress response, providing a link between the major mRNA and protein surveillance pathways in mammalian cells.

4.3. miRNA functions and mRNA turnover {#sec0065}
--------------------------------------

In order to exert their regulatory effects in gene expression, mature miRNAs in the cytoplasm associate with the ribonucleoprotein complex miRISC (miRNA-induced silencing complex), the core of which is composed of the Argonaute (AGO) proteins ([@bib0045]). The mechanisms used by miRISC to silence gene expression include inhibition of translation initiation or elongation, premature ribosomal drop-off and co-translational protein degradation, where the levels of target mRNA are not affected. Moreover, miRISC can accelerate mRNA decay by two distinct mechanisms; they direct endonucleolytic cleavage by AGOs, if the target mRNA is perfect complementary to the miRNA, or promote mRNA deadenylation and subsequently degradation by exoribonucleases, in cases of insufficient complementarity ([@bib0225], [@bib0245]). As most animal miRNAs are only partially complementary to their targets, translational repression and/or mRNA decay are the prevailing mechanisms of miRNA-mediated gene silencing. It is still under debate whether translational repression precedes mRNA deadenylation or there is interplay between the two regulatory mechanisms. Based on several *in vitro*, *in vivo* and genome-wide studies, a temporal model of miRNA-mediated gene silencing has been proposed ([@bib0235]). According to this model, miRNAs can inhibit translation initiation in a deadenylation-independent manner and subsequently can trigger deadenylation, destabilization and degradation through the typical mRNA decay pathways. It is also possible for translational repression and deadenylation to occur independently ([@bib0355]).

Several studies have shown that miRNA-repressed mRNAs, miRNAs, AGO and GW182 proteins, apart from their cytoplasmic localization, can be also detected in PBs ([@bib0005], [@bib0215], [@bib0630]). Although the localization of the silencing machinery into PBs is a consequence and not the cause of translational repression, in both human cells and *Drosophila* ([@bib0220], [@bib0630]), the accumulation of miRNA-repressed mRNAs in RNA granules such us PBs and SGs, could provide a rapid or adaptive response to specific developmental or stress conditions. In support to this, miR-122-repressed CAT-1 mRNA in human cells can be released from PBs and return to active translation during amino acid deprivation ([@bib0060]). Linked to the above is the finding that a subset of miRNAs and two miRISC components, PACT and AGO2, can associate with SGs and undergo dynamic exchange with polyribosomes in the cytoplasm of human cells under stress ([@bib0385], [@bib0490], [@bib0610]). The chaperone Hsp90 is critical for this association, as well as post-translational modifications of AGO2 by stress-induced signaling pathways that affect the ageing process, connecting miRNA activity to cellular stress and ageing ([@bib0205]). miRNA activity during stress and ageing can be also modulated by specific RNA-binding proteins that bind adjacent to miRNA binding sites and control the expression of the same target mRNA. Furthermore, stress can affect the expression or the processing of miRNAs through changes in related transcription factors or signaling molecules ([@bib0485]).

Although miRNA abundance is highly regulated at the biogenesis and processing levels, degradation mechanisms that control their half-lives are similarly important for miRNA homeostasis in all conditions. Several miRNAs display a dynamic expression pattern in a developmental stage- or tissue-specific manner without variation in the expression of miRNA precursors and various cellular conditions trigger rapid degradation of miRNAs ([@bib0455], [@bib0655]). Both 5'→3' and 3'→5' exoribonucleases have been linked to miRNA degradation ([@bib0035]), whereas autophagic clearance of the miRNA-free miRISC components, DICER and AGO2 has been reported in human cells ([@bib0295]). In *C. elegans*, the 5'→3' exoribonucleases XRN-1 and XRN-2 catalyze the degradation of AGO-unbound miRNAs ([@bib0110], [@bib0405]), whereas the scavenger decapping enzyme DCS-1 interacts with XRN-1 and stimulates miRNA degradation ([@bib0080]). All together these data suggest a plausible link between the mRNA decay machinery and miRNA levels/function, which can regulate gene expression during both stress and ageing.

5. Concluding remarks {#sec0070}
=====================

Regulation of mRNA stability in the cytoplasm represents an important means of post-transcriptional gene regulation in eukaryotes, in both normal and stress conditions. The mRNA decay rate or turnover determines the cytoplasmic abundance of all transcripts and is influenced by the assembly and function of specific RNA granules, termed PBs and SGs. They are sites of degradation or storage of un-translating mRNAs, with great importance under cellular or environmental conditions where a rapid and transient response is required. They have crucial roles during development and stress response/adaption but their role in ageing, a long-term process that may be regulated by short term stress responses, is also gradually emerging. A functional interplay between mRNA turnover mechanisms and well-known ageing modulators is depicted in [Fig. 3](#fig0015){ref-type="fig"}.

Major signaling pathways that modulate ageing and stress survival in diverse species can affect mRNA turnover by directly altering the levels, activity or localization of decay factors as well as of *trans*-acting elements (RBPs and miRNAs) of transcripts. mRNA turnover factors and related RNA granules can in turn influence the function and outcome of such signaling pathways by targeting downstream effectors or regulators of them. Reduced mRNA translation is an important longevity determinant and a first point of the integrated stress response. A reduction in mRNA translation is achieved by proper induction of mRNA decay/repression mechanisms and preserves protein homeostasis by preventing the production of excessive amounts of proteins. The function of quality control systems in turn can affect the abundance of both mRNA turnover factors and their respective RNA granules. miRNAs regulate a broad range of gene expression and may help to confer robustness during stress adaptation and ageing. Also, the degradation of miRNAs as well as their mRNA targets has been linked to typical mRNA decay factors whereas storage of miRNA-repressed mRNAs in PBs and SGs could provide a rapid or adaptive response to specific developmental or stress conditions. Taken together, mRNA turnover can modulate many aspects of the ageing process and a better understanding of the involved factors and mechanisms is needed. Such investigation may allow us to develop novel and multidisciplinary approaches for the study of the ageing process that could drive anti-ageing interventions for extending healthy lifespan.
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![General mRNA decay pathways. Bulk mRNA degradation is initiated with the shortening of the poly(A) tail by the combined action of CCR4/NOT and PAN2/PAN3 complexes, optionally followed by the addition of a short uridine tract at the 3' end. Subsequently, mRNAs can be degraded by two mechanisms: 3'-5' decay mediated by the exosome (with the aid of 3'-5' exoribonuclease DIS3L2, in the case of uridylated transcripts), or removal of the 5' cap by the DCP1/DCP2 decapping complex and 5'-3' decay mediated by XRN1 exonuclease. Translationally inactive and degradable transcripts can assemble in conjunction with their protein-binding partners into cytoplasmic RNA granules termed P-bodies (PBs). PBs are often found to dock, fuse or mature to stress granules, a different type of RNA granules, which contain mRNAs stalled in the process of translation initiation.](gr1){#fig0005}

![Accumulation of P-bodies (PBs) during stress and ageing. PBs are visualized in somatic cells of *C. elegans* using a translational fusion of DCAP-1 (the worm homologue of DCP1) with GFP. Confocal images of the head region of 1-day (Young) and 7-day adults (old) grown under normal conditions, or of young adults transiently subjected to heat--shock (stressed) are shown. Arrowheads indicate formed PBs. Scale bars = 50 μm.](gr2){#fig0010}

![Functional interplay between modulators of ageing and cytoplasmic mRNA decay mechanisms. Key ageing modulators such as signal transduction pathways, protein synthesis/homeostasis and miRNAs can regulate the translational silencing, storage or degradation of mRNAs, which can be occurred to specific cytoplasmic RNA granules (PBs and SGs). In turn, mRNA turnover factors and RNA granules can influence the function and outcomes of ageing modulators.](gr3){#fig0015}
